221
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Absolute lymphocyte count at day + 21 predicts survival in patients with early-stage diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, adriamycin, vincristine and prednisone

, , , , , , , , & show all
Pages 1757-1763 | Received 09 Nov 2011, Accepted 22 Feb 2012, Published online: 19 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Luis F. Porrata, Kay M. Ristow, Thomas M. Habermann, Thomas E. Witzig, Joseph P. Colgan, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Grzegorz Nowakowski, Carrie A. Thompson & Svetomir N. Markovic. (2014) Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:12, pages 2728-2738.
Read now

Articles from other publishers (8)

Leyre Bento, Antonio Díaz‐López, Gilberto Barranco, Ana M. Martín‐Moreno, Mónica Baile, Alejandro Martín, Juan M. Sancho, Olga García, Mario Rodríguez, Jose M. Sánchez‐Pina, Silvana Novelli, Antonio Salar, Mariana Bastos, M José Rodríguez‐Salazar, Sonia González de Villambrosia, Raul Córdoba, M. García‐Recio, J. Martínez‐Serra, Raquel Campo, Hugo Luzardo, Daniel García, Azueg Hong, Pau Abrisqueta, Jorge Sastre‐Serra, Pilar Roca, José Rodríguez & Antonio Gutiérrez. (2019) New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma treated with R‐CHOP: Spanish Lymphoma Group Experience (GELTAMO). British Journal of Haematology 188:6, pages 888-897.
Crossref
Jeongkuk SeoWon Seog KimJin Seok KimSeok Jin KimJae Hoon LeeJun Shik HongGyeong-Won LeeSung Yong OhJi-Hyun LeeDok Hyun YoonWon-Sik LeeHyo Jung KimJae-Yong KwakHye Jin KangJae-Cheol JoYong ParkHo Sup LeeHyo-Jin KimCheolwon Suh. (2017) Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial. Blood Research 52:3, pages 200.
Crossref
Chen Chang, Shang-Yin Wu, Yu-Wei Kang, Kun-Piao Lin, Tsai-Yun Chen, L. Jeffrey Medeiros & Kung-Chao Chang. (2015) High Levels of Regulatory T Cells in Blood Are a Poor Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma. American Journal of Clinical Pathology 144:6, pages 935-944.
Crossref
Emmanuel Bachy & Gilles Salles. (2015) Treatment Approach to Newly Diagnosed Diffuse Large B-Cell Lymphoma. Seminars in Hematology 52:2, pages 107-118.
Crossref
Vishal Narwani, Joseph Gabriel, Kevin Boyd & Timothy Chevassut. (2015) Absolute Lymphocyte Count at Day 29 of Treatment Is a Powerful Predictor of Outcome in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 15:4, pages 222-226.
Crossref
R. Vaidya & T.E. Witzig. (2014) Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. Annals of Oncology 25:11, pages 2124-2133.
Crossref
L F Porrata, K M Ristow, T M Habermann, W R Macon, T E Witzig, J P Colgan, D J Inwards, S M Ansell, I N Micallef, P B Johnston, G Nowakowski, C A Thompson & S N Markovic. (2013) Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma. Blood Cancer Journal 3:4, pages e110-e110.
Crossref
Fang Chongliang, Li Yuzhong, Shi Qian, Liu Xiliang & Liu Hui. (2013) Development of a Prognostic Score Using the Complete Blood Cell Count for Survival Prediction in Unselected Critically Ill Patients. BioMed Research International 2013, pages 1-4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.